# POU3F2

## Overview
POU3F2 is a gene that encodes the POU class 3 homeobox 2 protein, commonly referred to as BRN2, which is a transcription factor predominantly involved in neural development. The BRN2 protein is characterized by a conserved POU domain, which facilitates its DNA-binding capability, playing a critical role in the regulation of gene expression during neurodevelopmental processes. This transcription factor is essential for the differentiation and maturation of neural progenitor cells into neurons, particularly influencing the development of the cerebral cortex and the adult hippocampus. Beyond its role in normal brain development, POU3F2 is also implicated in various psychiatric disorders and cancers, where its expression levels and interactions with other molecular pathways can significantly impact disease progression and prognosis (Hashizume2017POU3F2; Dominguez2012POUIII; Xie2022Overexpression).

## Structure
The POU3F2 gene encodes the BRN2 protein, a transcription factor characterized by a conserved POU domain, which is crucial for its DNA-binding capability. The POU domain is composed of two subdomains: the N-terminal POUs and the C-terminal POUh, connected by a flexible linker. This domain facilitates interaction with DNA, primarily at the 5'-ATGCAAAT-3' octameric sequence (do2016In; Coelho2015Construction). The BRN2 protein consists of 443 amino acids and includes a transactivation N-terminal domain and a DNA-binding C-terminal domain (Coelho2015Construction).

The secondary structure of BRN2 is predominantly α-helical, with the POU domain featuring a helix-turn-helix motif, which is typical for DNA-binding proteins (do2016In). During molecular dynamics simulations, the recognition helices of the POU domain demonstrated stability and specific interactions with the DNA major groove, indicating strong binding affinity (do2016In). The protein structure also includes loop regions, contributing to its overall conformation and function (do2016In).

Post-translational modifications, such as phosphorylation, may influence the activity and stability of BRN2, although specific modifications are not detailed in the provided context. The structural insights into BRN2 are essential for understanding its role in gene regulation and potential therapeutic targeting in melanoma (do2016In).

## Function
POU3F2, also known as BRN2, is a transcription factor primarily expressed in the central nervous system, where it plays a crucial role in brain development and neural differentiation. It is involved in regulating neurodevelopmental genes and influences the differentiation of neural progenitor cells into neurons. POU3F2 promotes neuronal differentiation while limiting the proliferation of neural progenitor cells, indicating its role in maintaining the balance between cell proliferation and differentiation during brain development (Chen2018The).

In the cerebral cortex, POU3F2 is essential for the production and migration of upper-layer neurons, which are significant for cognitive functions. It influences the expression of genes like Tbr2 and Tbr1, which are critical for the development of glutamatergic cortical neurons (Dominguez2012POUIII). POU3F2 also interacts with other transcription factors and signaling pathways, such as Notch, to regulate neurogenesis and the specification of neuronal subtypes (Dominguez2012POUIII).

In the adult hippocampus, POU3F2 is involved in the maturation of newborn neurons, particularly in the dentate gyrus, and is associated with cognitive functions such as object and spatial recognition (Hashizume2017POU3F2). Its activity in the nucleus involves binding to specific DNA sequences to control the transcription of genes essential for these processes (Hashizume2017POU3F2).

## Clinical Significance
Alterations in the expression of the POU3F2 gene, also known as BRN2, have been implicated in various cancers. In triple-negative breast cancer (TNBC), POU3F2 is overexpressed, promoting proliferation, migration, and invasion of cancer cells. This overexpression is associated with poor prognosis and increased radioresistance, mediated through the Akt pathway (Xie2022Overexpression). In melanoma, POU3F2 expression is linked to a high somatic mutation burden and is involved in DNA damage repair processes. It suppresses apoptosis and promotes cell survival by interacting with DNA damage response factors, such as Ku70/Ku80 and PARP1, directing repair towards non-homologous end joining (Herbert2019BRN2).

In human colon cancer, POU3F2 expression is regulated by the ROS-p53 axis and influences the expression of tNOX, a protein associated with cell survival. In p53-null cells, POU3F2 upregulation enhances resistance to oxidative stress and chemotherapy, suggesting its role in cancer cell survival in p53-deficient systems (Chen2018Regulation). In hepatocellular carcinoma, POU3F2 is part of a competing endogenous RNA network with lncRNA BCYRN1 and miR-490-3p, contributing to tumor growth and metastasis (Ding2020LncRNA).

## Interactions
POU3F2, also known as BRN2, is a transcription factor that plays a significant role in neural development and psychiatric disorders. It interacts with various proteins and nucleic acids to regulate gene expression. POU3F2 is identified as a master regulator in gene coexpression networks, particularly in brain tissue from patients with psychiatric disorders such as schizophrenia and bipolar disorder. It regulates other transcription factors and miRNAs, including PAX6, SOX9, and hsa-miR-320e, forming a central hub in the disease-associated module (Chen2018The).

POU3F2 also interacts with the NTF3 gene, a novel target involved in neuronal differentiation. This interaction is crucial for neuronal differentiation, as evidenced by experiments showing that POU3F2 binds to the NTF3 promoter, influencing its transcriptional activity (Lin2018NTF3).

In the context of schizophrenia, POU3F2 regulates the expression of the TRIM8 gene, which is implicated in cellular functions related to the disorder. POU3F2 promotes TRIM8 expression, and this interaction is modulated by specific single nucleotide polymorphisms that affect POU3F2 binding efficiency (Ding2020Transcription). These interactions highlight POU3F2's role in neurodevelopment and its potential impact on psychiatric disorders.


## References


[1. (Ding2020Transcription) Chaodong Ding, Chunling Zhang, Richard Kopp, Liz Kuney, Qingtuan Meng, Le Wang, Yan Xia, Yi Jiang, Rujia Dai, Shishi Min, Wei-Dong Yao, Ma-Li Wong, Hongyu Ruan, Chunyu Liu, and Chao Chen. Transcription factor pou3f2 regulates trim8 expression contributing to cellular functions implicated in schizophrenia. Molecular Psychiatry, 26(7):3444–3460, September 2020. URL: http://dx.doi.org/10.1038/s41380-020-00877-2, doi:10.1038/s41380-020-00877-2. This article has 19 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1038/s41380-020-00877-2)

[2. (Coelho2015Construction) Ivan E. V. Coelho, Denise Costa Arruda, and Alex G. Taranto. Construction of brn2 protein in complex with more dna through in silico methods. Revista Processos Químicos, 9(18):128–132, July 2015. URL: http://dx.doi.org/10.19142/rpq.v9i18.277, doi:10.19142/rpq.v9i18.277. This article has 0 citations.](https://doi.org/10.19142/rpq.v9i18.277)

[3. (Chen2018Regulation) Huei-Yu Chen, Atikul Islam, Tien-Ming Yuan, Shi-Wen Chen, Pei-Fen Liu, and Pin Ju Chueh. Regulation of tnox expression through the ros-p53-pou3f2 axis contributes to cellular responses against oxaliplatin in human colon cancer cells. Journal of Experimental &amp; Clinical Cancer Research, July 2018. URL: http://dx.doi.org/10.1186/s13046-018-0837-9, doi:10.1186/s13046-018-0837-9. This article has 19 citations.](https://doi.org/10.1186/s13046-018-0837-9)

[4. (Dominguez2012POUIII) Martin H. Dominguez, Albert E. Ayoub, and Pasko Rakic. Pou-iii transcription factors (brn1, brn2, and oct6) influence neurogenesis, molecular identity, and migratory destination of upper-layer cells of the cerebral cortex. Cerebral Cortex, 23(11):2632–2643, August 2012. URL: http://dx.doi.org/10.1093/cercor/bhs252, doi:10.1093/cercor/bhs252. This article has 162 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1093/cercor/bhs252)

[5. (Lin2018NTF3) Yi-Mei J. Lin, I-Lun Hsin, H. Sunny Sun, Shankung Lin, Yen-Ling Lai, Hsuan-Ying Chen, Ting-Yu Chen, Ya-Ping Chen, Yi-Ting Shen, and Hung-Ming Wu. Ntf3 is a novel target gene of the transcription factor pou3f2 and is required for neuronal differentiation. Molecular Neurobiology, 55(11):8403–8413, March 2018. URL: http://dx.doi.org/10.1007/s12035-018-0995-y, doi:10.1007/s12035-018-0995-y. This article has 25 citations and is from a peer-reviewed journal.](https://doi.org/10.1007/s12035-018-0995-y)

[6. (Herbert2019BRN2) Katharine Herbert, Romuald Binet, Jean-Philippe Lambert, Pakavarin Louphrasitthiphol, Halime Kalkavan, Laura Sesma-Sanz, Carla Daniela Robles-Espinoza, Sovan Sarkar, Eda Suer, Sarah Andrews, Jagat Chauhan, Nicola D. Roberts, Mark R. Middleton, Anne-Claude Gingras, Jean-Yves Masson, Lionel Larue, Paola Falletta, and Colin R. Goding. Brn2 suppresses apoptosis, reprograms dna damage repair, and is associated with a high somatic mutation burden in melanoma. Genes &amp; Development, 33(5–6):310–332, February 2019. URL: http://dx.doi.org/10.1101/gad.314633.118, doi:10.1101/gad.314633.118. This article has 34 citations.](https://doi.org/10.1101/gad.314633.118)

[7. (Hashizume2017POU3F2) K. Hashizume, M. Yamanaka, and S. Ueda. Pou3f2 participates in cognitive function and adult hippocampal neurogenesis via mammalian‐characteristic amino acid repeats. Genes, Brain and Behavior, 17(2):118–125, August 2017. URL: http://dx.doi.org/10.1111/gbb.12408, doi:10.1111/gbb.12408. This article has 29 citations.](https://doi.org/10.1111/gbb.12408)

8. (Xie2022Overexpression) Overexpression of POU3F2 promotes radioresistance in triple-negative breast cancer via Akt pathway activation. This article has 0 citations.

[9. (Ding2020LncRNA) Shichao Ding, Yanfeng Jin, Qingzhi Hao, Yanmeng Kang, and Ruiping Ma. Lncrna bcyrn1/mir-490-3p/pou3f2, served as a cerna network, is connected with worse survival rate of hepatocellular carcinoma patients and promotes tumor cell growth and metastasis. Cancer Cell International, January 2020. URL: http://dx.doi.org/10.1186/s12935-019-1081-x, doi:10.1186/s12935-019-1081-x. This article has 22 citations and is from a peer-reviewed journal.](https://doi.org/10.1186/s12935-019-1081-x)

[10. (do2016In) Ivan Evangelista do Vale Coelho, Denise Costa Arruda, and Alex Gutterres Taranto. In silico studies of the interaction between brn2 protein and more dna. Journal of Molecular Modeling, August 2016. URL: http://dx.doi.org/10.1007/s00894-016-3078-x, doi:10.1007/s00894-016-3078-x. This article has 3 citations and is from a peer-reviewed journal.](https://doi.org/10.1007/s00894-016-3078-x)

[11. (Chen2018The) Chao Chen, Qingtuan Meng, Yan Xia, Chaodong Ding, Le Wang, Rujia Dai, Lijun Cheng, Preethi Gunaratne, Richard A. Gibbs, Shishi Min, Cristian Coarfa, Jeffrey G. Reid, Chunling Zhang, Chuan Jiao, Yi Jiang, Gina Giase, Amber Thomas, Dominic Fitzgerald, Tonya Brunetti, Annie Shieh, Cuihua Xia, Yongjun Wang, Yunpeng Wang, Judith A. Badner, Elliot S. Gershon, Kevin P. White, and Chunyu Liu. The transcription factor pou3f2 regulates a gene coexpression network in brain tissue from patients with psychiatric disorders. Science Translational Medicine, December 2018. URL: http://dx.doi.org/10.1126/scitranslmed.aat8178, doi:10.1126/scitranslmed.aat8178. This article has 84 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1126/scitranslmed.aat8178)